Press-centre
Latest news
Prev
Next
Measures to support the medical industry in the production and promotion of domestic medical products in national and foreign markets
08-11-2019
Roman Shabrov, partner at BRACE Law Firm, will take part in a joint meeting of the RF CCI Committee on the Development of the Procurement System, the RF CCI Committee on Entrepreneurship in the Health Care and Medical Industry and the Interdepartmental Coordinating Council of the military-industrial complex collegium on the development of medical products in defense industry organizations on...
Digest of regulation of pharmaceutical industry for September 2019, prepared by BRACE Law Firm
23-10-2019
We are glad to propose to your attention the Digest of legal regulation of the Russian pharmaceutical industry for September 2019, prepared by BRACE Law Firm.
Round table on the topic “Combating corporate fraud, measures to prevent collusion and theft in enterprises” at the Moscow Chamber of Commerce and Industry
08-10-2019
Roman Shabrov, partner of BRACE Law Firm, took part in the round table of the Guild of Trade and Services Enterprises of the Moscow Chamber of Commerce and Industry on October 4, 2019.
Digest of regulation of pharmaceutical industry for August 2019, prepared by BRACE Law Firm
11-09-2019
We are glad to propose to your attention the digest of legal regulation of the Russian pharmaceutical industry for August 2019, prepared by BRACE Law Firm.
Digest of regulation of pharmaceutical industry for July 2019, prepared by BRACE Law Firm
16-08-2019
We are glad to propose to your attention the digest of legal regulation of the Russian pharmaceutical industry for July 2019, prepared by BRACE Law Firm.
Digest of regulation of pharmaceutical industry for June 2019, prepared by BRACE Law Firm
12-07-2019
We are glad to propose to your attention the digest of legal regulation of the Russian pharmaceutical industry for June 2019, prepared by BRACE Law Firm. In June 2019, the Federal Law dated 06.06.2019 No. 134-FZ was adopted, which established the list of cases when pharmaceutical companies are obliged to reduce the maximum selling prices for drugs from the VED list.
